Astrana Health, Inc. (ASTH) Stock Overview
Explore Astrana Health, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Astrana Health, Inc. (ASTH)
Key Financials
Key Financials
Market Cap
1.9B
P/E Ratio
45.83
EPS (TTM)
$0.83
ROE
0.05%
ASTH Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Astrana Health, Inc. (NASDAQ: ASTH) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Astrana Health, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of ASTH on the NASDAQ shows an RSI of 46.36, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $29.46 for the NASDAQ listing.
Key metrics behind Astrana Health, Inc.'s NASDAQ-traded stock include a P/E ratio of 45.83 and a market capitalization of 1.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ASTH on the NASDAQ.